PDGFR? promoter polymorphisms and expression patterns influence risk of development of imatinib-induced thrombocytopenia in chronic myeloid leukemia: A study from India.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Oct 39 (10): 1010428317713857.
Guru Sameer Ahmad, Mir Rashid, Bhat Musadiq, Najar Imtiyaz, Zuberi Mariyam, Sumi Mamta, Masroor Mirza, Gupta Naresh, Saxena Alpa
Sunitinib as a second-line therapy for advanced GISTs after failure of imatinib: relationship between efficacy and tumor genotype in Korean patients.
Investigational new drugs 2012 Apr 30 (2): 819-27.
Yoon Dok Hyun, Ryu Min-Hee, Ryoo Baek-Yeol, Beck Moyeol, Choi Dae Ro, Cho Yoojin, Lee Jae-Lyun, Chang Heung-Moon, Kim Tae Won, Kang Yoon-K